Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Affymax, Inc.
Affymax to Present at Citi’s 4th Annual Biotech Day
April 10th, 2009
Affymax, Inc. (Nasdaq: AFFY) announced that Paul B. Cleveland, the company’s chief financial officer and executive vice president of corporate development, will present at Citi’s 4th Annual Biotech Day at 3:20 p.m. ET on April 1, 2009 in New York, NY. A live webcast of the presentations will be available on the investors section of the Company’s website at www.affymax.com. A replay will also be available for 30 days following the presentation. About Affymax, Inc. Affymax, Inc. is a biopharmaceutical company developing novel drugs to improve the treatment of serious and often life-threatening conditions. Affymax’s product candidate, Hematide™, is currently in Phase 3...
Source: Health Business Week (2009-04-10)
|
